TOP AGO TUMOR SECRETS

Hormonal therapy stays the therapy of to start with choice for metastatic people with endocrine-responsive breast cancer (LoE 1a A, AGO ++). The sequential use with the offered medication depends on the person pretreatment. Reassessment of ER, PR, and HER2 in tumor tissue at the time of diagnosis of relapse is usually recommended Anytime doable, as